Hostname: page-component-5d59c44645-hb754 Total loading time: 0 Render date: 2024-02-28T23:48:30.350Z Has data issue: false hasContentIssue false

Susceptibility of human papillomavirus 16 to disinfectants

Published online by Cambridge University Press:  01 October 2021

Cary A. Moody*
Affiliation:
Division of Infectious Diseases, Department of Microbiology and Immunology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina
William A. Rutala
Affiliation:
Division of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina
Maria F. Gergen
Affiliation:
Hospital Epidemiology, University of North Carolina Health, Chapel Hill, North Carolina
Deverick J. Anderson
Affiliation:
Division of Infectious Diseases, Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University Medical Center, Durham, North Carolina
Emily E. Sickbert-Bennett
Affiliation:
Division of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina Hospital Epidemiology, University of North Carolina Health, Chapel Hill, North Carolina
David J. Weber
Affiliation:
Division of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina Hospital Epidemiology, University of North Carolina Health, Chapel Hill, North Carolina
*
Author for correspondence: Cary A. Moody, E-mail: camoody@med.unc.edu

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Brief
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Meyers, J, Ryndock, E, Conway, MJ, Meyers, C, Robison, R. Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants. J Antimicrob Chemother 2014,69;15461550.Google ScholarPubMed
Rutala, WA, Weber, DJ. Registration of disinfectants based on relative microbicidal activity. Infect Control Hosp Epidemiol 2004;25:333341.Google ScholarPubMed
Ozbun, MA, Bondu, V, Patterson, NA, et al. Infectious titres of human papillomaviruses (HPVs) in patient lesions, methodological considerations in evaluating HPV infectivity and implications for the efficacy of high-level disinfectants. EBioMedicine 2021;63:103165.Google ScholarPubMed
Egawa, N, Shiraz, A, Crawford, R, et al. Dynamics of papillomavirus in vivo disease formation and susceptibility to high-level disinfection—implications for transmission in clinical settings. EBioMedicine 2021;63:103177.Google ScholarPubMed
Christensen, ND, Dillner, J, Eklund, C, et al. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology 1996;223:174184.Google ScholarPubMed
Ozbun, MA. Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription. J Virol 2002;76:1129111300.Google ScholarPubMed
Culp, TD, Christensen, ND. Kinetics of in vitro adsorption and entry of papillomavirus virions. Virology 2004;319:152161.Google ScholarPubMed
McDonnell, G, Russell, AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999;12:147179.Google ScholarPubMed
Rutala, WA, Weber, DJ, HICPAC. Guideline for disinfection and sterilization in healthcare facilities, 2008. Centers for Disease Control and Prevention website. https://www.cdc.gov/infectioncontrol/pdf/guidelines/disinfection-guidelines-H.pdf. Accessed September 21, 2021.Google Scholar
Fischer, M, Renevey, N, Thur, B, Hoffmann, D, Beer, M, Hoffmann, B. Efficacy assessment of nucleic acid decontamination reagents used in molecular diagnostic laboratories. PLoS One 2016;11:e0159274.Google ScholarPubMed